“…As reported in many in vitro and in vivo studies, these molecules are elective factors for oral infection and biomaterials to treat early carious lesions, promote cell adhesion, and enhance the adhesion strength of dental implants while preventing infection at the surgery site [25]. However, the small amount of data regarding animal models or clinical trials is a limitation for the future use of this biomaterial containing AMPs [25]. In this Special Issue, Cunha and coworkers developed a clinical trial to evaluate in vivo the antimicrobial properties and dental efficacy of a nisin-biogel in dogs [26].…”